BeOne Medicines AG
NASDAQ:ONC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
NASDAQ:ONC
|
CH |
|
A
|
Ameriprise Financial Inc
F:A4S
|
US |
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
PAR:BAIN
|
MC |
|
A
|
A2A SpA
F:EAM
|
IT |
|
A
|
Atoss Software AG
XHAM:AOF
|
DE |
|
FinVolution Group
NYSE:FINV
|
CN |
|
U
|
Updater Services Ltd
NSE:UDS
|
IN |
|
G
|
Guangdong Investment Ltd
F:GUG
|
HK |
|
H
|
Hanjaya Mandala Sampoerna Tbk PT
XMUN:HSZ
|
ID |
|
Shofu Inc
F:69W
|
JP |
|
TPG Telecom Ltd
ASX:TPG
|
AU |
|
IPD Group Ltd
F:IS6
|
AU |
|
N
|
National Grid PLC
F:NNGD
|
UK |
|
Grupo Aeroportuario del Centro Norte SAB De CV
F:G7AB
|
MX |
|
Z
|
Zijin Mining Group Co Ltd
F:FJZB
|
CN |
|
P
|
Paladin Energy Ltd
XMUN:PUR
|
AU |
|
V
|
Viohalco SA
ATHEX:VIO
|
BE |
|
P
|
Paladin Energy Ltd
F:PUR
|
AU |
|
Grande Portage Resources Ltd
XTSX:GPG
|
CA |
|
C
|
Coral Laboratories Ltd
BSE:524506
|
IN |
|
ODK Solutions Co Ltd
TSE:3839
|
JP |
|
E
|
EQT Corp
XMUN:EQ6
|
US |
|
NKGen Biotech Inc
OTC:NKGN
|
US |
|
T
|
Toray Industries Inc
OTC:TRYIF
|
JP |
Wall St Price Targets
ONC Price Targets Summary
BeOne Medicines AG
According to Wall Street analysts, the average 1-year price target for ONC is 519.75 USD with a low forecast of 433.76 USD and a high forecast of 670.06 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ONC's stock price target?
Price Target
519.75
USD
According to Wall Street analysts, the average 1-year price target for ONC is 519.75 USD with a low forecast of 433.76 USD and a high forecast of 670.06 USD.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next 6 years is 10%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.